Connect with us

Hi, what are you looking for?

Economy

Delta (DAL), AMD, Walgreens (WBA), or Constellation Energy (CEG): which stock to buy and which to skip

Investors face a sea of choices when it comes to selecting the right stocks.

Let’s delve into the recent performance, market sentiment, and prospects of four key players—Delta Air Lines (DAL), AMD, Walgreens (WBA), and Constellation Energy Corporation (CEG)—to determine which stocks are worth buying and which may be better left out of your portfolio.

Walgreens (WBA): a risky turnaround play

Walgreens reported better-than-expected fiscal first-quarter results, with adjusted earnings per share of $0.51 surpassing analyst expectations of $0.37.

Revenue also grew to $39.46 billion, a 7.5% year-over-year increase, beating the expected $37.36 billion.

WBA chart by TradingView

Despite these beats, Walgreens faces significant challenges, including operating losses and store closures as part of a multiyear restructuring plan.

While the company’s retail pharmacy segment has shown growth, increasing sales by 6.6%, retail sales declined due to weaker consumer spending and reduced demand for discretionary products.

The turnaround plan could eventually stabilize Walgreens, but with ongoing pressures like reimbursement challenges and cost-cutting measures, its future remains uncertain.

Verdict: Skip. Despite positive earnings, Walgreens carries too much risk in the short term due to its ongoing restructuring.

Constellation Energy Corporation (CEG): a promising utility stock

CEG is currently enjoying strong investor sentiment, reflected in its Average Brokerage Recommendation (ABR) of 1.67, which places it between a “Strong Buy” and “Buy.”

The company’s strong earnings outlook has led analysts to revise the Zacks Consensus Estimate for 2025 EPS upwards to $8.31, showing increased optimism about the company’s financial performance.

CEG chart by TradingView

As a utility company, Constellation Energy benefits from a stable and predictable revenue model, which is appealing to risk-averse investors.

However, it is essential to keep in mind that brokerage recommendations often come with inherent biases. Investors should validate these with their research.

Verdict: Buy. With solid growth potential and a strong market position, CEG is a safer long-term bet.

Advanced Micro Devices (AMD): facing competitive headwinds

AMD’s recent performance has been mixed.

Goldman Sachs downgraded AMD from “Buy” to “Neutral,” citing increased competition in the GPU and PC markets and a weaker outlook for traditional server units.

The firm also lowered its price target from $175 to $129. AMD’s revenue estimates for 2025/26 have been cut, reflecting these challenges.

AMD chart by TradingView

While AMD has been a major player in the semiconductor space, its lesser exposure to high-growth AI segments compared to competitors like Nvidia has hindered its stock performance.

AMD’s shares fell 5.6% recently, further illustrating the market’s cautious outlook.

Verdict: Skip. The downgrade and competitive pressures make AMD less attractive compared to peers like Nvidia and Broadcom.

Delta Air Lines (DAL): flying high with momentum

Delta posted strong results for 2024, reporting a full-year operating revenue of $61.6 billion.

Its Q4 adjusted earnings per share of $1.85 exceeded the expected $1.76, showcasing its resilience in a competitive airline industry.

CEO Ed Bastian has emphasized growth in corporate bookings and international travel, signaling robust demand for air travel.

DAL chart by TradingView

Delta also anticipates $4 billion in free cash flow for 2025, which it plans to invest in fleet expansion and technological upgrades.

With consistent on-time performance and a focus on premium services, Delta has positioned itself as a leader in the airline industry.

Verdict: Buy. Delta’s strong financials, growth trajectory, and strategic investments make it a compelling choice for investors.

While the analysis of Delta (DAL), AMD, Walgreens (WBA), and Constellation Energy (CEG) provides a snapshot of their current positions, investors need to dig deeper before making investment decisions.

Each stock comes with unique opportunities and risks—be it AMD’s exposure to AI and chip competition, Delta’s reliance on travel demand, Walgreens’ ongoing turnaround efforts, or CEG’s favorable analyst ratings.

Factors like industry trends, competitive dynamics, and economic conditions can significantly impact these companies’ performances.

Investors are encouraged to assess their financial health, growth potential, and alignment with personal risk tolerance and goals.

The post Delta (DAL), AMD, Walgreens (WBA), or Constellation Energy (CEG): which stock to buy and which to skip appeared first on Invezz

You May Also Like

Latest News

LONDON (Reuters) – Demand for London’s most expensive homes cooled last month as high earners worried about the possibility of tax increases by Britain’s...

Latest News

Investing.com — The idea of a U.S. Sovereign Wealth Fund has been gaining attention, with both former President Donald Trump and current President Joe...

Latest News

(Reuters) – Bank of Canada Governor Tiff Macklem opened the door to increasing the pace of interest rate cuts, the Financial Times reported on...

Editor's Pick

Venezuela, a country blessed with natural wealth and stunning landscapes, faces a tourism paradox. Despite its abundant resources, the nation struggles to attract international...

Disclaimer: Bullsmarketdominators.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


Copyright © 2024 Bullsmarketdominators.com